Know Cancer

or
forgot password

    • cancer clinical trials in flagstaff, AZ

    • Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer
    Pfizer Investigational Site
    Flagstaff, Arizona 86001
    Advanced Breast Cancer, Breast Cancer
    A Study of Nilotinib Versus Imatinib in GIST Patients
    Northern Arizona Hematology/Oncology Associates, P.C. Dept. of No. AZ Hem-Onc
    Flagstaff, Arizona 86001
    Gastrointestinal Stromal Tumor (GIST)
    A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma
    Pfizer Investigational Site
    Flagstaff, Arizona 86001
    Solid Tumor, Kidney Neoplasms, Advanced Renal Cell Carcinoma
    ARCHER 1009 : A Study Of PF-00299804 (Dacomitinib) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Flagstaff, Arizona 86001
    Non-Small Cell Lung Cancer (NSCLC)
    Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer
    Pfizer Investigational Site
    Flagstaff, Arizona 86001
    Breast Neoplasms
    Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
    Pfizer Investigational Site
    Flagstaff, Arizona 86001
    Non-Hodgkin Lymphoma, Hodgkin Disease, Thrombocytopenia
    AG-013736 In Combination With Docetaxel Versus Docetaxel Alone For Patients With Metastatic Breast Cancer
    Pfizer Investigational Site
    Flagstaff, Arizona 86001
    Breast Neoplasms
    A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients
    Northern Arizona Hematology and Oncology Associates
    Flagstaff, Arizona 86001
    Non-Small Cell Lung Cancer
    Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.
    Pfizer Investigational Site
    Flagstaff, Arizona 86001
    Colorectal Neoplasms
    Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).
    Pfizer Investigational Site
    Flagstaff, Arizona 86001
    Colorectal Neoplasms
    Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer
    Pfizer Investigational Site
    Flagstaff, Arizona 86001
    Carcinoma, Non-Small-Cell Lung
    Study Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid Tumors
    Pfizer Investigational Site
    Flagstaff, Arizona 86001
    Neoplasms
    Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women
    Pfizer Investigational Site
    Flagstaff, Arizona 86001
    Osteoporosis
    Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Flagstaff, Arizona 86001
    Carcinoma, Non-Small Cell Lung
    Expanded Access Program for Maraviroc At Multiple Centers
    Pfizer Investigational Site
    Flagstaff, Arizona 86001
    Advanced HIV Infection
    A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone
    Pfizer Investigational Site
    Flagstaff, Arizona 86001
    Carcinoma, Non-Small Cell Lung
    Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology
    Pfizer Investigational Site
    Flagstaff, Arizona 86001
    Carcinoma, Squamous Cell, Carcinoma, Adenosquamous, Carcinoma, Large Cell, Carcinoma, Non-Small-Cell Lung
    Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer
    Pfizer Investigational Site
    Flagstaff, Arizona 86001
    Colorectal Neoplasms
    Platinum Resistant Ovarian Cancer Evaluation of Doxil and EC145 Combination Therapy
    Northern Arizona Hematology and Oncology Associates
    Flagstaff, Arizona 86001
    Ovarian Cancer
    Follow-Up Study for Exubera
    Pfizer Investigational Site
    Flagstaff, Arizona 86001
    Diabetes Mellitus
    A Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid Tumors
    Pfizer Investigational Site
    Flagstaff, Arizona 86001
    Advanced Solid Tumors, Neoplasms, Carcinoma, Cancer, Malignancy
    Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors
    Pfizer Investigational Site
    Flagstaff, Arizona 86001
    Advanced Solid Tumors, Neoplasms, Carcinoma, Cancer, Malignancy
    A Safety, Tolerability, And Pharmacokinetic Trial With CVX-241 In Patients With Advanced Solid Tumors
    Pfizer Investigational Site
    Flagstaff, Arizona 86001
    Advanced Solid Tumors, Epithelial Ovarian Cancer (EOC) or Primary Peritoneal Cancer (PPC)
    PF-04856884 (CVX-060) In Combination With Axitinib In Patients With Previously Treated Metastatic Renal Cell Carcinoma
    Pfizer Investigational Site
    Flagstaff, Arizona 86001
    Metastatic Renal Cell Carcinoma
    CP-751,871 Treatment For Patients With Multiple Myeloma
    Pfizer Investigational Site
    Flagstaff, Arizona 86001
    Multiple Myeloma